| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2018 | Association of EV71 3C polymorphisms with clinical severity | Ma, HY; Lu, CY; Tsao, KC; Shih, HM ; Cheng, AL; Huang, LM; Chang, LY | J Microbiol Immunol Infect. 51(5), 608-613 | | | |
| 1993 | Expression of P-glycoprotein and glutathione-S-transferase in recurrent lymphomas: the possible role of Epstein-Barr virus, immunophenotypes, and other predisposing factors. | Cheng, AL; Su, IJ; Chen, YC; Lee, TC; Wang, CH | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 11(1), 109-15 | | | |
| 2014 | Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma | Liao, F; Hsu, YC; Kuo, SH; Yang, YC; Chen, JP; Hsu, PN; Lin, CW; Chen, LT; Cheng, AL; Fann, CS; Lin, JT; Wu, MS | Blood Cancer Journal 4, eXX | | | |
| 2015 | Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma. | Ou, DL; Shyue, SK; Lin, LI; Feng, ZR; Liou, JY; Fan, HH; Lee, BS; Hsu, C; Cheng, AL | Oncotarget 6(29), 27953-27965 | | | |
| 2015 | High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country | Lin, CH; Shen, CY; Lee, JH; Huang, CS; Yang, CH; Kuo, WH; Chang, DY; Hsiung, CN; Kuo, KT; Chen, WW; Chen, IC; Wu, PF; Kuo, SH; Chen, CJ; Lu, YS; Cheng, AL | PLoS One 10(4), e0124908 | | | |
| 2018 | The HER2 inhibitor lapatinib potentiates doxorubicin-induced cardiotoxicity through iNOS signaling | Hsu, WT; Huang, CY; Yen, CYT; Cheng, AL; Hsieh, PC | Theranostics 8(12), 3176-3188 | | | |
